A detailed history of Investment Management Associates Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Investment Management Associates Inc holds 2,319 shares of ABBV stock, worth $398,241. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,319
Previous 2,283 1.58%
Holding current value
$398,241
Previous $391,000 16.88%
% of portfolio
0.08%
Previous 0.13%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$163.84 - $199.33 $5,898 - $7,175
36 Added 1.58%
2,319 $457,000
Q2 2024

Aug 01, 2024

BUY
$154.79 - $180.76 $2,012 - $2,349
13 Added 0.57%
2,283 $391,000
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $250,156 - $281,735
-1,818 Reduced 44.47%
2,270 $351,000
Q2 2023

Aug 01, 2023

BUY
$132.51 - $164.9 $132 - $164
1 Added 0.02%
4,088 $550,000
Q1 2023

May 02, 2023

SELL
$144.61 - $166.54 $18,220 - $20,984
-126 Reduced 2.99%
4,087 $651,000
Q4 2022

Feb 02, 2023

SELL
$138.31 - $165.87 $7,330 - $8,791
-53 Reduced 1.24%
4,213 $681,000
Q3 2022

Nov 01, 2022

SELL
$134.21 - $153.93 $14,628 - $16,778
-109 Reduced 2.49%
4,266 $573,000
Q1 2022

May 02, 2022

SELL
$131.98 - $163.75 $1.09 Million - $1.36 Million
-8,294 Reduced 65.47%
4,375 $709,000
Q4 2021

Feb 16, 2022

SELL
$107.43 - $135.93 $387,607 - $490,435
-3,608 Reduced 22.17%
12,669 $1.72 Million
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $194,605 - $220,906
1,829 Added 12.66%
16,277 $1.76 Million
Q2 2021

Jul 30, 2021

BUY
$105.21 - $117.21 $43,451 - $48,407
413 Added 2.94%
14,448 $1.63 Million
Q1 2021

May 07, 2021

BUY
$102.3 - $112.62 $269,151 - $296,303
2,631 Added 23.07%
14,035 $1.52 Million
Q4 2020

Mar 16, 2021

BUY
$80.49 - $108.67 $917,907 - $1.24 Million
11,404 New
11,404 $1.22 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Investment Management Associates Inc Portfolio

Follow Investment Management Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Management Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Investment Management Associates Inc with notifications on news.